Novo Nordisk's pricing methods in the U.S. have drawn sharp criticism from lawmakers like Senator Sanders, that has accused the company of rate gouging, stating the stark distinction involving U.S. charges and people in Europe and copyright.This led Novo Nordisk to carry out further research into bigger dosages of semaglutide especially for weight